Dr Pooja Chawla is working as a Professor and the head at the Department of Pharmaceutical Analysis, ISF College of Pharmacy Moga, India. She has nearly 13 years of experience in the research, discovery and development of biologically active pharmaceuticals. Dr Chawla holds a PhD degree in Medicinal Chemistry and has published 3 books and more than 40 papers in national/international journals. She is currently serving as a reviewer for international journals of repute. She also presented a poster at FIP in 2011 and CTDDR in 2013 and delivered an oral talk at the World Chemistry Congress, Dubai 2019. She has guided 47 post-graduate projects, and her research team involves 3 master and 2 doctoral research scholars.
Malvina Hoxha Catholic University Our Lady of Good Counsel Tirana (Albania)
Dr. Hoxha is a researcher and lecturer of pharmacology at the Catholic University ‘Our Lady of Good
Counsel’, Tirana, Albania. She graduated in pharmacy (Summa cum Laude), and obtained her PhD in
pharmacology at the Department of Pharmacological and Biomolecular Sciences, University of Milan.
Her area of research is focused mainly on arachidonic acid metabolites and their role in different in-
flammatory diseases. Dr. Hoxha attended a post-doctorate at the University of Granada, Spain, and
recently she obtained a research award from the Austrian Academy of Science. In 2019, she was elected as a national delegate
of the ERS (European Respiratory Society).
Aristeidis H. Katsanos McMaster University Hamilton, ON (Canada)
Aristeidis H. Katsanos, MD, Ph.D., is currently a clinical fellow in stroke medicine at the McMaster
University, Hamilton, Ontario, Canada. He received his graduate and post-graduate degrees from the
University of Ioannina School of Medicine, Greece. His research focuses on the evidence-based evalu-
ation of emerging diagnostic and therapeutic approaches to acute stroke treatment and secondary
stroke prevention. He has a particular enthusiasm for epidemiology, biostatistics and meta-research. He
has actively participated in numerous research projects and international collaborations and has published more than 140 papers
in high-impact medical journals, indexed in PubMed, which according to Google Scholar, have received more than 1981 cita-
tions (H-index 26), to date.
Y. Minzhong University Hospitals Cleveland Medical Center Cleveland, OH (USA)
Dr. Yu Minzhong received a PhD in Visual Neurobiology/Clinical Electrophysiology of Vision from the Hong Kong Polytechnic University, Hong Kong. His broad background is in clinical and experimental electrophysiology of vision, and visual neurobiology, with specific training and expertise in key research areas related to retinal diseases particularly in understanding the pathways of oxidative stress and endoplasmic reticulum stress associated with genetic mutations in retinitis pigmentosa. Over the past 35 years, he has mastered techniques in electrophysiology and molecular biology to understand the mechanism of retinal degeneration. During his PhD study, he was a pioneer in studying multifocal VEP in patients. During postdoctoral training, he worked on the cellular mechanisms of mutant mouse models with electrophysiologic techniques, including AC ERG, VEP and DC ERG (a unique technique for RPE function test). Moreover, he has contributed his valuable publications in different scientific journals.
Hari S. Sharma Uppsala University Uppsala (Sweden)
Dr. Hari Shanker Sharma obtained his PhD in 1982 from Banaras Hindu University and Dr Med Sci in 1999 from Uppsala University and engaged in Neuroscience research over 40 years. He is currently the Director of Research International Experimental CNS Injury & Repair (IECNSIR) based at Uppsala University. He authored more than 250 original research papers and Edited several Books in Progress in Brain Research Series and International Review of Neurobiology series. His current research includes Nano delivery of drugs to treat CNS injury and enhance neurorepair.
K. Xiong Central South University Changsha (China)
Prof. Kun Xiong is the Chairman of the Department of Anatomy & Neurobiology at the School of Basic Medical Science, Central South University. His research interests include the regulatory mechanisms of neuronal death, including apoptosis and necroptosis in brain disorders and glaucoma. Prof. Kun Xiong earned his Bachelor of Medicine (Clinical Medicine) and PhD degrees in human anatomy at Central South University. He has worked as a visiting scholar at the Department of Anatomy in the School of Medicine, Southern Illinois University, US. Notably, Prof. Kun Xiong’s research has been funded by more than 10 foundations, including 4 National Natural Science Foundations of China. He has authored 60 manuscripts. He has also served as a reviewer for multiple international journals and as an editorial member for several journals (Medicine and Neural Regeneration Research, etc.).
H. Zhang Shanghai University of Traditional Chinese Medicine Shanghai (China)
Dr. Hong Zhang received his PhD degree in Formulaology from Chengdu University of Traditional Chinese Medicine in 2005. He joined the Second Military Medical University as a Lecturer in 2005 and became an Associate Professor in 2009. He worked as a specially invited research fellow for Shanghai Seventh People’s Hospital from 2014 to 2018. He moved to Shanghai University of Traditional Chinese Medicine as an Associate Professor in 2018. Dr Zhang has undertaken more than 25 projects, applied for 15 patents, and published 9 books and more than 140 articles. His research interests are focused on the activity screening, target and compatibility mechanism for Chinese medicines and natural products.
Edoardo Spina Department of Clinical and Experimental Medicine University of Messina Policlinico Universitario Via Consolare Valeria Messina (Italy)
Dr. Spina graduated in Medicine, specialized in Neurology and in Psychiatry at the University of Messina, Italy. He obtained a doctorate (Ph.D) in Clinical Pharmacology at Karolinska Institute, Stockholm. Currently, Dr. Spina is Professor of Pharmacology at the Department of Clinical and Experimental Medicine, University of Messina. His main scientific interest is clinical neuropsychopharmacology. Dr. Spina authored more than 200 articles in international journals and 2 books. He is Associate Editor of Frontiers in Pharmacogenetics and member of the editorial board of Therapeutic Drug Monitoring, Basic & Clinical Pharmacology & Toxicology and Neuropsychiatric Disease and Treatment.